Search Results 41-50 of 15107 for risksas
About this study. The purpose of this study is to evaluate the effectiveness of percutaneous epidural spinal stimulation (ES) and task-specific training ...
About this study. The purpose of this study is to evaluate the effectiveness and safety of mepolizumab adjunctive therapy in participants with severe ...
Inclusion Criteria: 18 years of age or older. Severe brachial plexus injury. Considering upper limb amputation. Exclusion Criteria: 17 years old or younger.
The purpose of this study is to further characterize the serum and Cerebral Spinal Fluid (CSF) biomarker profile of idiopathic normal pressure hydrocephalus ...
Inclusion Criteria: Patients who have signed an electronic or paper controlled substance agreement within the palliative medicine clinic.
The primary purpose of this study is to determine if bortezomib, daratumumab, lenalidomide and dexamethasone (Btz-DRd) consolidation followed by daratumumab ...
Inclusion Criteria: Subjects must be 18 years of age or older. Have a Body Mass Index ≥ 18.5 kg/m2 and < 40 kg/m^2 as confirmed by InBody measurement.
About this study. The purpose of this study is to build a Mayo Clinic registry of data and biobank from subjects with drug allergy.
About this study. The purpose of this study is to determine the extent to which patients who survive severe drug eruptions suffer long-term end organ damage ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.